Skip to main content Skip to footer

Consumer health—strategy and technology

With the right technology partner, spin-offs can claim a substantial stake in a rapidly expanding industry within one of the world’s most dynamic sectors.

Strategy and technology promise to shape the future of consumer health, and our expertise covers the full value chain—from R&D, manufacturing, supply chain, commercial and procurement to finance, strategy, sales and marketing. With deep knowledge and experience in consumer goods, life sciences, healthcare and retail industries, we’re giving consumer goods companies the power to transform experiences, reimagine processes and future-proof their businesses.

It’s why 23 of the top 30 global consumer goods companies partner with us. It’s why we’ve recently been ranked among the top 10 retail and CPG services providers by HFS Research. And it’s why we have a trusted presence in all top 30 global biopharma companies and 12 of the leading 15 global medtech organisations. What’s more: Life sciences contributes more than 10% of our business and is a globally diversified practice where we are a recognised leader.

How life sciences companies can ride the AI wave to competitive success

The trend of spinning off consumer healthcare companies is gaining momentum.

Insights

Emergence of digital therapeutics

By empowering patients to take control of their own conditions, digital therapeutics is beginning to solve some of the biggest challenges to modern-day healthcare.

Woman writing
The metaverse could revolutionise – and democratise – healthcare

Explore four ways the metaverse could transform healthcare for patients and medical professionals.

Cognizant office
It’s time for CX to come of age in life sciences

Organisations are building their strength in CX particularly and transforming engagement at every step of the customer journey.

Read more
Deep Green

The future of sustainability in business: data, technology and collaboration

Group of people having a conversation
Webinar
logo

The role of big pharma in consumer healthcare | Webinar

How and why are spin-offs taking place and what are the market implications?

A recent trend has emerged for large pharmaceutical companies to separate out their consumer health arms.

I am convinced that newly formed consumer health companies will have the freedom to pivot to new operating models for growth as pharma companies look to create financial value and sharpen their market focus. This presents real opportunity.

Rohit Alimchandani
Head of Life Sciences UK&I
Cognizant

Gregory Verlinden